##plugins.themes.academic_pro.article.main##

Abstract

Pterygium is a conjunctival-corneal degeneration, accompanied by the growth of fibrovascular tissue along the surface of the cornea. Presumably, the most important provoking factor is ultraviolet radiation. In addition, the influence of factors such as changes in the tear film, imbalance of cytokines, growth factors, immunological mechanisms, genetic mutations, as well as viral diseases is being studied. However, there may be such manifestations of dry eye syndrome as itching, burning, or lacrimation caused by uneven moisture in the ocular surface. Further spread of the pterygium into the optical zone reduces visual acuity and requires surgical treatment. Countries close to the equator (countries with high UV exposure) and people working with dust have 18-20% more cases of the disease than other countries. The study found that out of 1081 patients with pterygium disease, 355 were women and 724 were men. When studying the disease in cities and regions, it turned out that it is more common in the city of Urgench and in people aged 40-65 years. As a recommendation, the prevention of any disease, less walks in the light of the sun, dusty air and compliance with the rules of hygiene, as well as the timely conduct of comprehensive medical examinations are a necessary factor in the prevention of any disease for human health.

Keywords

pterygium elastoid dysplasia proliferative fibromatosis

##plugins.themes.academic_pro.article.details##

How to Cite
Radjabov Hamid Rashid ugli. (2022). Spread Of Pterygium Disease In Khorezm Region. Texas Journal of Medical Science, 4, 28–31. https://doi.org/10.62480/tjms.2022.vol4.pp28-31

References

  1. Hovanesian J. Pterygium: Techniques and Technologies for Surgical Success. Thorofare, NJ: SLACK; 2012 2-5
  2. Roobins & Cotran south asia edition “Pathologic Basis of Disease” on page 1323
  3. Luthra R, Nemesure B, Wu S, Xie S, Leske M. (2001). Frequency and risk factors for pterygiumin the Barbados Eye Study. Arch Ophthalmol.119:1827-32
  4. Vojnikovic B, Njiric S, Cocklo M, Toth I, Spanjol J, Marinovic M. (2007). Sunlight and incidence of pterigium on Croatian Island Rab: epidemiological study. Coll Antropol, 31:61-2.
  5. K. R. Kenyon, M. D. Wagoner, and M. E. Hettinger. (1985). Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. vol. 92, no. 11, pp. 1461-70.
  6. J. Cano-Parra, M. Diaz-Liopis, M. J. Maldonado, E. Vila, and J. L. Menezo. (1995). Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. British Journal of Ophthalmology. vol. 79, no. 5, pp. 439-41.
  7. Abiose A. (1997). Treatment of pterygium in Lagos, Nigeria. E Afr Med J. 54:327-31.
  8. Alpay A, Ugurbas SH, Erdogan B. (2009). Comparing techniques for pterygium surgery. Clin Ophthalmol. 3:69-74.
  9. Sutphin JE. (2008). Basic and Clinical Science Course: External disease and cornea. San Francisco:American Academy of Ophthalmology. 8: 394, 429-32.
  10. Almond MC, Dastrup BT, Kaufman SC. (2012). 5-fluorouracil and mitomycin-C: adjuncts to pterygium surgery. In: Hovanesian JA, editor. Pterygium: Techniques and Technologies for Surgical Success. Thorofare, NJ: Slack Incorporated. 55-64.
  11. Ang LP, Chua JL, Tan DT. (2007). Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol. 18:308-13.